多参数磁共振多个感兴趣区与融合穿刺检出临床显著前列腺癌无关
该单中心回顾性研究纳入381例接受磁共振-超声融合穿刺的男性,分析穿刺前多参数磁共振多个感兴趣区(PI-RADS≥3)与临床显著前列腺癌(Gleason≥7)检出的关联。调整分析显示年龄、BMI、PSA及PI-RADS 4/5与检出显著相关,而多个感兴趣区与检出无关(OR 1.05,95%CI 0.60-1.84,p=0.857)。
要点
- 多个感兴趣区不增加临床显著前列腺癌检出概率。
- PI-RADS 4和5仍与临床显著前列腺癌检出独立相关。
- 多个感兴趣区不应影响融合穿刺决策。
核心结论
- 多个感兴趣区不预示临床显著前列腺癌检出率更高。
- 医生应认识到多个感兴趣区不应影响融合穿刺决策。
研究设计与样本
- 单中心回顾性分析,纳入381例接受磁共振-超声融合穿刺的男性。
- 排除既往活检阳性、外院磁共振或PI-RADS v2发布前磁共振者。
主要发现
- 年龄(OR 1.10,95%CI 1.06-1.15,p≤0.001)、BMI(OR 1.08,95%CI 1.01-1.16,p=0.038)和PSA(OR 1.06,95%CI 1.01-1.10,p=0.015)与临床显著前列腺癌检出相关。
- PI-RADS 4(OR 4.62,95%CI 2.23-9.33)和5(OR 6.75,95%CI 2.72-16.71,p<0.001)与临床显著前列腺癌检出几率更高相关。
- 多个感兴趣区与临床显著前列腺癌检出无关(OR 1.05,95%CI 0.60-1.84,p=0.857)。
临床怎么用
- 临床决策中不应因多个感兴趣区而增加融合穿刺的倾向。
- 可利用该结果缓解患者对多个感兴趣区的焦虑。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We sought to determine the association between multiple regions of interest on prebiopsy magnetic resonance imaging and the detection of clinically significant prostate cancer in men undergoing magnetic resonance imaging-ultrasound fusion biopsy. MATERIALS AND METHODS: We performed a retrospective, single institution analysis of men who underwent fusion biopsy. Men with prior positive biopsies, magnetic resonance imaging performed elsewhere and/or magnetic resonance imaging prior to release of the PI-RADS™ (Prostate Imaging Reporting and Data System) version 2 were excluded from study, resulting in 381 participants. Modeled independent variables included patient age, number of regions of interest with a PI-RADS categorization of 3 or greater, body mass index, prostate specific antigen, prostate volume and PI-RADS categorization. Multivariable logistic regression was performed to determine factors associated with finding clinically significant prostate cancer (Gleason 7 or greater) on biopsy. RESULTS: Median age was 67.2 years (IQR (61.6-73.0) and median prostate specific antigen was 6.6 ng/ml (5.0-10.0). Adjusted analysis demonstrated that age (OR 1.10, 95% CI 1.06-1.15, p ≤0.001), body mass index (OR 1.08, 95% CI 1.01-1.16, p = 0.038) and prostate specific antigen (OR 1.06, 95% CI 1.01-1.10, p = 0.015) were associated with detection of clinically significant prostate cancer. PI-RADS categories 4 (OR 4.62, 95% CI 2.23-9.33) and 5 (OR 6.75, 95% CI 2.72-16.71, each p <0.001) were associated with greater odds of clinically significant prostate cancer. Multiple regions of interest were not associated with the detection of clinically significant prostate cancer (OR 1.05, 95% CI 0.60-1.84, p = 0.857). CONCLUSIONS: Multiple regions of interest do not portend a greater likelihood of finding clinically significant prostate cancer. Physicians should recognize that multiple regions of interest should not influence the decision to perform fusion biopsy. Our findings may ease patient anxiety concerning these findings.
引用
- Patel N, Halpern JA, Kasabwala K, et al. Multiple Regions of Interest on Multiparametric Magnetic Resonance Imaging are Not Associated with Increased Detection of Clinically Significant Prostate Cancer on Fusion Biopsy. J Urol. 2018. PMID: 29518433. doi:10.1016/j.juro.2018.03.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。